BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29106905)

  • 1. Characterisation of endogenous A
    Goulding J; May LT; Hill SJ
    Biochem Pharmacol; 2018 Jan; 147():55-66. PubMed ID: 29106905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
    Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capadenoson, a clinically trialed partial adenosine A
    Baltos JA; Vecchio EA; Harris MA; Qin CX; Ritchie RH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2017 Jul; 135():79-89. PubMed ID: 28344125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The A
    Mølck C; Ryall J; Failla LM; Coates JL; Pascussi JM; Heath JK; Stewart G; Hollande F
    Cancer Lett; 2016 Dec; 383(1):135-143. PubMed ID: 27693637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
    Vecchio EA; Tan CY; Gregory KJ; Christopoulos A; White PJ; May LT
    J Pharmacol Exp Ther; 2016 Apr; 357(1):36-44. PubMed ID: 26791603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
    Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
    Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of adenosine A
    Carlin JL; Jain S; Duroux R; Suresh RR; Xiao C; Auchampach JA; Jacobson KA; Gavrilova O; Reitman ML
    Neuropharmacology; 2018 Sep; 139():268-278. PubMed ID: 29548686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regionally selective cardiovascular responses to adenosine A
    Cooper SL; Wragg ES; Pannucci P; Soave M; Hill SJ; Woolard J
    FASEB J; 2022 Apr; 36(4):e22214. PubMed ID: 35230706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSB 603 - a known selective adenosine A2B receptor antagonist - has anti-inflammatory activity in mice.
    Kotańska M; Szafarz M; Mika K; Dziubina A; Bednarski M; Müller CE; Sapa J; Kieć-Kononowicz K
    Biomed Pharmacother; 2021 Mar; 135():111164. PubMed ID: 33385856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tritium-labeled agonists as tools for studying adenosine A
    Hinz S; Alnouri WM; Pleiss U; Müller CE
    Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modulators of human A2B adenosine receptor.
    Trincavelli ML; Giacomelli C; Daniele S; Taliani S; Cosimelli B; Laneri S; Severi E; Barresi E; Pugliesi I; Greco G; Novellino E; Da Settimo F; Martini C
    Biochim Biophys Acta; 2014 Mar; 1840(3):1194-203. PubMed ID: 24361612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric Antagonism of the A
    Gao ZG; Toti KS; Campbell R; Suresh RR; Yang H; Jacobson KA
    Cells; 2020 May; 9(5):. PubMed ID: 32408534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel curcumin analog (cis-trans curcumin) as ligand to adenosine receptors A
    Hamilton LJ; Walker M; Pattabiraman M; Zhong HA; Luedtke B; Chandra S
    Pharmacol Res; 2021 Mar; 165():105410. PubMed ID: 33401004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A
    De Filippo E; Hinz S; Pellizzari V; Deganutti G; El-Tayeb A; Navarro G; Franco R; Moro S; Schiedel AC; Müller CE
    Biochem Pharmacol; 2020 Feb; 172():113718. PubMed ID: 31751537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
    Ongini E; Dionisotti S; Gessi S; Irenius E; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):7-10. PubMed ID: 9933143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine inhibition of rat carotid body chemoreceptors is mediated by A2A and A2B adenosine receptors.
    Conde SV; Obeso A; Vicario I; Rigual R; Rocher A; Gonzalez C
    J Neurochem; 2006 Jul; 98(2):616-28. PubMed ID: 16805851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A
    Jiang J; Seel CJ; Temirak A; Namasivayam V; Arridu A; Schabikowski J; Baqi Y; Hinz S; Hockemeyer J; Müller CE
    J Med Chem; 2019 Apr; 62(8):4032-4055. PubMed ID: 30835463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts.
    Xi J; McIntosh R; Shen X; Lee S; Chanoit G; Criswell H; Zvara DA; Xu Z
    J Mol Cell Cardiol; 2009 Nov; 47(5):684-90. PubMed ID: 19695259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells.
    Cooper J; Hill SJ; Alexander SP
    Br J Pharmacol; 1997 Oct; 122(3):546-50. PubMed ID: 9351513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.